Peripheral blood stem cell collection from G-CSF-stimulated unrelated donors for second transplant

G. Dini, W. Arcese, M. Barbanti, F. Biffoni, A. Bosi, E. Lanino, I. Majolino, G. Menichella, G. Reali

Research output: Contribution to journalArticle

Abstract

Peripheral blood stem cells (PBSCs) collected following stimulation with cytokines are commonly used for autologous haematopoietic transplants. Currently, PBSCs are being used for syngeneic or allogeneic transplants from matched or haploidentical donors. However, many issues are still unanswered regarding the early or late side-effects cytokines have on recipients and on healthy donors. The aims of this paper were to evaluate the experience acquired worldwide in this field, to define the acceptability of stem cell donation by G-CSF-stimulated apheresis from unrelated donors after the failure of a first donation, and to assess side-effects of G-CSF on unrelated donors. The use of PBSCs has increased tremendously over the last few years and in the near future PBSCs will probably become the most relevant source of stem cells. Studies conducted so far have definitely concluded that G-CSF is safe and well tolerated. Results observed in transplants utilizing marrow stem cells compared with results obtained in transplants utilizing PBSCs have shown that patients undergoing this latter procedure recover earlier, require a lower number of transfusions and spend fewer days in hospital with a consequent decrease in costs. We concluded that a second transplant by G-CSF-stimulated apheresis from an unrelated donor is definitely acceptable and we designed a prospective study to better define all controversial aspects. Donors will be given 10 μg/kg/day of G-CSF subcutaneously for 5 days. One or two PBSC collection procedures will be performed: the first on day 5 and the second, if necessary, on day 6. Donors will be surveyed and blood counts monitored in a standardized manner during the process.

Original languageEnglish
JournalBone Marrow Transplantation
Volume21
Issue numberSUPPL. 5
Publication statusPublished - 1997

Fingerprint

Unrelated Donors
Granulocyte Colony-Stimulating Factor
Transplants
Tissue Donors
Blood Component Removal
Stem Cells
Cytokines
Autografts
Peripheral Blood Stem Cells
Bone Marrow
Prospective Studies
Costs and Cost Analysis

Keywords

  • G-CSF
  • PBSC transplant
  • Second transplant
  • UDBMT

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Cite this

Dini, G., Arcese, W., Barbanti, M., Biffoni, F., Bosi, A., Lanino, E., ... Reali, G. (1997). Peripheral blood stem cell collection from G-CSF-stimulated unrelated donors for second transplant. Bone Marrow Transplantation, 21(SUPPL. 5).

Peripheral blood stem cell collection from G-CSF-stimulated unrelated donors for second transplant. / Dini, G.; Arcese, W.; Barbanti, M.; Biffoni, F.; Bosi, A.; Lanino, E.; Majolino, I.; Menichella, G.; Reali, G.

In: Bone Marrow Transplantation, Vol. 21, No. SUPPL. 5, 1997.

Research output: Contribution to journalArticle

Dini, G, Arcese, W, Barbanti, M, Biffoni, F, Bosi, A, Lanino, E, Majolino, I, Menichella, G & Reali, G 1997, 'Peripheral blood stem cell collection from G-CSF-stimulated unrelated donors for second transplant', Bone Marrow Transplantation, vol. 21, no. SUPPL. 5.
Dini, G. ; Arcese, W. ; Barbanti, M. ; Biffoni, F. ; Bosi, A. ; Lanino, E. ; Majolino, I. ; Menichella, G. ; Reali, G. / Peripheral blood stem cell collection from G-CSF-stimulated unrelated donors for second transplant. In: Bone Marrow Transplantation. 1997 ; Vol. 21, No. SUPPL. 5.
@article{554fbd78a069489da14537dc5ef9f66d,
title = "Peripheral blood stem cell collection from G-CSF-stimulated unrelated donors for second transplant",
abstract = "Peripheral blood stem cells (PBSCs) collected following stimulation with cytokines are commonly used for autologous haematopoietic transplants. Currently, PBSCs are being used for syngeneic or allogeneic transplants from matched or haploidentical donors. However, many issues are still unanswered regarding the early or late side-effects cytokines have on recipients and on healthy donors. The aims of this paper were to evaluate the experience acquired worldwide in this field, to define the acceptability of stem cell donation by G-CSF-stimulated apheresis from unrelated donors after the failure of a first donation, and to assess side-effects of G-CSF on unrelated donors. The use of PBSCs has increased tremendously over the last few years and in the near future PBSCs will probably become the most relevant source of stem cells. Studies conducted so far have definitely concluded that G-CSF is safe and well tolerated. Results observed in transplants utilizing marrow stem cells compared with results obtained in transplants utilizing PBSCs have shown that patients undergoing this latter procedure recover earlier, require a lower number of transfusions and spend fewer days in hospital with a consequent decrease in costs. We concluded that a second transplant by G-CSF-stimulated apheresis from an unrelated donor is definitely acceptable and we designed a prospective study to better define all controversial aspects. Donors will be given 10 μg/kg/day of G-CSF subcutaneously for 5 days. One or two PBSC collection procedures will be performed: the first on day 5 and the second, if necessary, on day 6. Donors will be surveyed and blood counts monitored in a standardized manner during the process.",
keywords = "G-CSF, PBSC transplant, Second transplant, UDBMT",
author = "G. Dini and W. Arcese and M. Barbanti and F. Biffoni and A. Bosi and E. Lanino and I. Majolino and G. Menichella and G. Reali",
year = "1997",
language = "English",
volume = "21",
journal = "Bone Marrow Transplantation",
issn = "0268-3369",
publisher = "Nature Publishing Group",
number = "SUPPL. 5",

}

TY - JOUR

T1 - Peripheral blood stem cell collection from G-CSF-stimulated unrelated donors for second transplant

AU - Dini, G.

AU - Arcese, W.

AU - Barbanti, M.

AU - Biffoni, F.

AU - Bosi, A.

AU - Lanino, E.

AU - Majolino, I.

AU - Menichella, G.

AU - Reali, G.

PY - 1997

Y1 - 1997

N2 - Peripheral blood stem cells (PBSCs) collected following stimulation with cytokines are commonly used for autologous haematopoietic transplants. Currently, PBSCs are being used for syngeneic or allogeneic transplants from matched or haploidentical donors. However, many issues are still unanswered regarding the early or late side-effects cytokines have on recipients and on healthy donors. The aims of this paper were to evaluate the experience acquired worldwide in this field, to define the acceptability of stem cell donation by G-CSF-stimulated apheresis from unrelated donors after the failure of a first donation, and to assess side-effects of G-CSF on unrelated donors. The use of PBSCs has increased tremendously over the last few years and in the near future PBSCs will probably become the most relevant source of stem cells. Studies conducted so far have definitely concluded that G-CSF is safe and well tolerated. Results observed in transplants utilizing marrow stem cells compared with results obtained in transplants utilizing PBSCs have shown that patients undergoing this latter procedure recover earlier, require a lower number of transfusions and spend fewer days in hospital with a consequent decrease in costs. We concluded that a second transplant by G-CSF-stimulated apheresis from an unrelated donor is definitely acceptable and we designed a prospective study to better define all controversial aspects. Donors will be given 10 μg/kg/day of G-CSF subcutaneously for 5 days. One or two PBSC collection procedures will be performed: the first on day 5 and the second, if necessary, on day 6. Donors will be surveyed and blood counts monitored in a standardized manner during the process.

AB - Peripheral blood stem cells (PBSCs) collected following stimulation with cytokines are commonly used for autologous haematopoietic transplants. Currently, PBSCs are being used for syngeneic or allogeneic transplants from matched or haploidentical donors. However, many issues are still unanswered regarding the early or late side-effects cytokines have on recipients and on healthy donors. The aims of this paper were to evaluate the experience acquired worldwide in this field, to define the acceptability of stem cell donation by G-CSF-stimulated apheresis from unrelated donors after the failure of a first donation, and to assess side-effects of G-CSF on unrelated donors. The use of PBSCs has increased tremendously over the last few years and in the near future PBSCs will probably become the most relevant source of stem cells. Studies conducted so far have definitely concluded that G-CSF is safe and well tolerated. Results observed in transplants utilizing marrow stem cells compared with results obtained in transplants utilizing PBSCs have shown that patients undergoing this latter procedure recover earlier, require a lower number of transfusions and spend fewer days in hospital with a consequent decrease in costs. We concluded that a second transplant by G-CSF-stimulated apheresis from an unrelated donor is definitely acceptable and we designed a prospective study to better define all controversial aspects. Donors will be given 10 μg/kg/day of G-CSF subcutaneously for 5 days. One or two PBSC collection procedures will be performed: the first on day 5 and the second, if necessary, on day 6. Donors will be surveyed and blood counts monitored in a standardized manner during the process.

KW - G-CSF

KW - PBSC transplant

KW - Second transplant

KW - UDBMT

UR - http://www.scopus.com/inward/record.url?scp=0031544564&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031544564&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0031544564

VL - 21

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

SN - 0268-3369

IS - SUPPL. 5

ER -